CN
627-75-8
应用筛选条件
关键词:'627-75-8'
显示 1-30 共 32 条结果 关于 "627-75-8" 范围 技术文档
Brain-Derived Neurotrophic Factor human (B3795)
the neurotrophins during
nervous system development: what the knockouts
are teaching us. Cell, 77, 627 (1994).
3. Encinas, M. et al., Sequential treatment of
SH-SY5Y cells with retinoic acid
Data Sheet - B3795
neurotrophins
during nervous system development: what the
knockouts are teaching us. Cell, 77, 627 (1994).
3. Encinas, M. et al., Sequential treatment of
SH-SY5Y cells with retinoic acid and brain-derived
Data Sheet - B3796
neurotrophins
during nervous system development: what the
knockouts are teaching us. Cell, 77, 627 (1994).
3. Encinas, M. et al., Sequential treatment of
SH-SY5Y cells with retinoic acid and brain-derived
Data Sheet - SRP3014
the neurotrophins
during nervous system development: what the
knockouts are teaching us. Cell, 77, 627 (1994).
3. Encinas, M. et al., Sequential treatment of
SH-SY5Y cells with retinoic acid and
Data Sheet - G7017
., Adv. Pharmacol., 42, 343-346
(1998).
2. Van Bocxlaer, J.F. et al., Clin. Chem., 43(4),
627-634 (1997).
3. Pizarro, N. et al., J. Anal. Toxicol., 26(3),
157-165 (2002).
4. Yang, C.-
GOAT ANTI-CHOLINE ACETYLTRANSFERASE (ChAT)
1483, #624.2.
8. Brain Research Bulletin (1990) 25:129-137.
9. Brain Research Bulletin (1992) 29:635-642.
10. Neuroscience Letters (1992) 147:217-220.
11. Brain Research (1993) 627:49-54
12. Neurobiology
MAK373- Technical Bulletin Final
and Potts, K.E., Protease inhibitors as
antiviral agents. Clin. Microbiol. Rev., 11, 614-627
(1998).
8. Medintz, I., et al., Proteolytic activity monitored by
fluorescence resonance energy transfer
Product Information Sheet-cdp-ro
chemiluminescent substrate for alkaline phosphatase.
Cat. No. 11 685 627 001 1 ml
Cat. No. 11 759 051 001 2 x 1 ml
Store the product at +2 to +8°C.
https://www.sigmaaldrich.com
XP725 Antibody Number-Lot Number 071M4826
-b c-d e-f g-h a-b c-d e-f g-h a-b c-d e-f g-h
1.1 1 2 3 4 25 26 27 28 49 50 51 52 73 74 75 76
1.2 5 6 7 8 29 30 31 32 53 54
MAK375- Technical Bulletin Final
K.E., Protease inhibitors as
antiviral agents. Clin. Microbiol. Rev., 11, 614-627
(1998).
3
8. Medintz, I., et al., Proteolytic activity monitored by
fluorescence
Anti-NeuN, clone A60 - Data Sheet
1996) 383:624-627.
4) J. Neuroscience (1997) 17:5820-5829.
5) J. Neuroscience (1997) 17:7415-7424.
6) J. Neuroscience (1998) 18:3206-3212.
7) J. Neuroscience (1998) 18:5614-5629.
8) J. Neuroscience
Product Information Sheet-11699075001
the surface.
• Dilute Anti-Digoxigenin-AP,
Fab fragments* 1:10,000 (75 mU/ml) in
1x Blocking solution.
Store at +2 to +8°C
for 12 hours.
Binding to the DIG-
labeled probe.
Color Substrate
Balancing Histone/Protein Acetylation-Gene Regulation and Cancer Therapy
Roth, S.Y., Curr. Opin. Genet. Dev., 11, 155-161
(2001).
16. Kuo, M.H., et al., Genes Dev., 12, 627-639 (1998).
17. Wang, L., et al., Genes Dev., 12, 640-653 (1998).
18. Grant, P.A., et al., Cell
Article: Virus filtration process development optimization
Antibodies Using Ion
Exchange Membrane Adsorptive Pre-Filtration.
Biotechnol. Bioeng. 106(4) 2010: 627–637.
5 Lit No. RF1013EN00 Rev. B, 11/14 DP SBU-
12-07371: Viresolve® Pro Solution Performance
Guide
An Update on Ligands for Prostanoid Receptors
C.S., et al., Prostaglandins, 53, 83-90 (1997).
70. Whittle, B.J., et al., Prostaglandins, 19, 605-627 (1980).
71. Skuballa, W., Vorbruggen, H., Adv. Prost. Thromb. Leukot. Res., 11, 229-305 (1983).
72.
Magna ChIP™ HT96
hm
en
t
Antibody Performance Using
Magna ChIP HT96 Panel II
1 84 108
133 212
627
1219
1935
0
500
1000
1500
2000
2500
C
on
EZ-Magna ChIP™ HT96 (Cat. No. 17-10078)
hm
en
t
Antibody Performance Using
Magna ChIP HT96 Panel II
1 84 108
133 212
627
1219
1935
0
500
1000
1500
2000
2500
C
on
Magna ChIP™ HT96 (Cat. No. 17-10077)
hm
en
t
Antibody Performance Using
Magna ChIP HT96 Panel II
1 84 108
133 212
627
1219
1935
0
500
1000
1500
2000
2500
C
on
BioFiles-Issue
Lissamine, Alexa 555
Atto 590 598 634 80 120000 HeNe laser Texas Red, Alexa 594
Atto 594 601 627 85 120000 HeNe laser Texas Red, Alexa 594
Atto 610 605 646 70
Material Matters Vol. 1, No. 1
�, 17, 53. (6) Brahim, S. et al.
Electroanalysis. �00�, 14(9), 627. (7) Rubio Retama, J. et al. Biosens. Bioelectron.
�004, 20, 1111. (8) Brahim, S. et al. Microchimica Acta �00�, 143, 123. (9)
Abraham
Biowire Fall 2010 - Breakthroughs in Biology
amplifi-
cation product from three input quantities was tested (Figure 8): 6.25
ng (similar to the kit-equivalent of 5 ng per 75 ul reaction) (1), 391 pg
(just less than the 800 pg demarcation observed
XP725 Antibody List Lot 129K4830
5747 PTK2 P NP_001186578.1 y y y
266 phospho-FAK (pTyr397) F7926 5747 PTK2 P NP_001186578.1 y y y
627 RAD1 R5029 5810 RAD1 P NP_002844.1 y n/d n/d
556 Paxillin P1093 5829 PXN M NP_001074324.1 y n/d y
623
XP725 Antibody List Lot 129K4831
5747 PTK2 P NP_001186578.1 y y y
266 phospho-FAK (pTyr397) F7926 5747 PTK2 P NP_001186578.1 y y y
627 RAD1 R5029 5810 RAD1 P NP_002844.1 y n/d n/d
556 Paxillin P1093 5829 PXN M NP_001074324.1 y n/d y
623
XP725 Antibody List Lot 089K4791
5747 PTK2 P NP_001186578.1 y y y
266 phospho-FAK (pTyr397) F7926 5747 PTK2 P NP_001186578.1 y y y
627 RAD1 R5029 5810 RAD1 P NP_002844.1 y n/d n/d
556 Paxillin P1093 5829 PXN M NP_001074324.1 y n/d y
623
Advanced Applications of Engineered Nanomaterials
toluene) 590 595 - 611 24 4.0-4.3 2.5 ~50%
CdSe 610 Dispersion (25 mg in 5 mL toluene) 610 518 - 627 25 4.7-5.2 3.7 ~50%
CdSe 640 Dispersion (25 mg in 5 mL toluene) 640 639 -
List of Antibodies
Rab5 R7904 M y y y
624 Anti Cy3+Cy5 C0992 M NA NA NA
625 Rab 7 R8779 M y y y
626 Rab9 R5404 M y y y
627 RAD1 R5029 P y n/d n/d
628 Rad17 (C-terminal) (C-terminal) R8029 P y n/d n/d
629
Material Matters Volume 15 number 2 Batteries & Solar Cells
Holt, M. V; Cai, Z.;
Bawendi, M. G.; Huang, L.; Buonassisi, T.; Fenning, D. P. Science 2019,
363, 627–631.
(18) Saliba, M.; Matsui, T.; Seo, J.-Y.; Domanski, K.; Correa-Baena, J.-P.;
Nazeeruddin, M
XP725 Worksheet for Lot Number 071M4826
www.sigmaaldrich.com/ProductLookup.html?ProdNo=C0992&Brand=SIGMA�
624 4 1 6 8 Anti CY3/5 C0992
625 4 2 1 1 GRP75 G4170
626 4 2 1 2 GRP75 G4170
627 4 2 1 3 GRP78 BiP G8918
628 4 2 1 4 GRP78 BiP
XP725 Antibody List
.4 M y y y
626 Rab9 R5404 84589, 9367, 56382 RAB9,Rab9 NP_445910.1,NP_004242.1,NP_062747.1 M y y y
627 RAD1 R5029 5810 RAD1 NP_596868.1 P y n/d n/d
628 Rad17 (C-terminal) R8029 5884 RAD17 NP_579922.1 P
XP725 Antibody List 013M4793
.4 M y y y
626 Rab9 R5404 84589, 9367, 56382 RAB9,Rab9 NP_445910.1,NP_004242.1,NP_062747.1 M y y y
627 RAD1 R5029 5810 RAD1 NP_596868.1 P y n/d n/d
628 Rad17 (C-terminal) R8029 5884 RAD17 NP_579922.1 P
1/2